<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941028-2-00221</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=24 g=1 f=1 --> Supplement 1_Determining the infectiousness of a TB patient <!-- PJG 0012 frnewline --> Noninfectiousness <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> Intensive-care units <!-- PJG 0012 frnewline --> Intermediate-risk area <!-- PJG 0012 frnewline --> Isolation practices <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> Dental settings <!-- PJG 0012 frnewline --> Discontinuation <!-- PJG 0012 frnewline --> Facilitating patient adherence <!-- PJG 0012 frnewline --> For multidrug-resistant TB <!-- PJG 0012 frnewline --> Initiation <!-- PJG 0012 frnewline --> Intensive-care units <!-- PJG 0012 frnewline --> Keeping door to room closed <!-- PJG 0012 frnewline --> Long-term-care facilities <!-- PJG 0012 frnewline --> Minimizing access to room <!-- PJG 0012 frnewline --> Patient education <!-- PJG 0012 frnewline --> Pediatric patients <!-- PJG 0012 frnewline --> Visitors <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> Isolation rooms <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> Air changes per hour (ACH) <!-- PJG 0012 frnewline --> Air exhaust <!-- PJG 0012 frnewline --> Anteroom <!-- PJG 0012 frnewline --> Grouping <!-- PJG 0012 frnewline --> HEPA filtration <!-- PJG 0012 frnewline --> Keeping door to room closed <!-- PJG 0012 frnewline --> Negative pressure <!-- PJG 0012 frnewline --> Number required <!-- PJG 0012 frnewline --> Purpose <!-- PJG 0012 frnewline --> Ultraviolet germicidal irradiation (UVGI) <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> Isoniazid (INH) <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> During pregnancy <!-- PJG 0012 frnewline --> Hepatitis <!-- PJG 0012 frnewline --> Monitoring for adverse reactions <!-- PJG 0012 frnewline --> Preventive therapy regimen <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> Laboratories <!-- PJG 0012 frnewline --> Local exhaust ventilation <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> Discharge from booths, tents, and hoods <!-- PJG 0012 frnewline --> Exterior devices <!-- PJG 0012 frnewline --> Into TB isolation rooms <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> Long-term-care facilities <!-- PJG 0012 frnewline --> Low-risk area <!-- PJG 0012 frnewline --> Medical offices <!-- PJG 0012 frnewline --> Medical record review <!-- PJG 0012 frnewline --> Minimal-risk facility <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Mycobacterium avium <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 -->  complex <!-- PJG 0012 frnewline --> National Institute for Occupational Safety and Health (NIOSH) <!-- PJG 0012 frnewline --> Negative pressure <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> Alternate methods for achieving <!-- PJG 0012 frnewline --> Definition <!-- PJG 0012 frnewline --> Monitoring <!-- PJG 0012 frnewline --> Pressure differential required <!-- PJG 0012 frnewline --> Pressure-sensing devices <!-- PJG 0012 frnewline --> Pressurizing the corridor <!-- PJG 0012 frnewline --> Smoke-tube testing <!-- PJG 0012 frnewline --> TB isolation rooms <!-- PJG 0012 frnewline --> Tents and booths <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> Nosocomial transmission <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> Factors promoting <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> Occupational groups <!-- PJG 0012 frnewline --> Occupational Safety and Health Administration (OSHA) <!-- PJG 0012 frnewline --> Operating rooms <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> Anterooms <!-- PJG 0012 frnewline --> Respiratory protection <!-- PJG 0012 frnewline --> Ventilation <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> OSHA respiratory protection standard <!-- PJG 0012 frnewline --> Outbreaks of TB in health-care facilities <!-- PJG 0012 frnewline --> Patient-to-patient transmission <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> Cohorting <!-- PJG 0012 frnewline --> Investigating <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> Pediatric patients <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Pneumocystis carinii <!-- PJG 0012 frnewline --> PPD reading <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> Cut-points for risk groups <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> PPD testing <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> Analysis of increased conversion rate <!-- PJG 0012 frnewline --> Anergy <!-- PJG 0012 frnewline --> BCG vaccination <!-- PJG 0012 frnewline --> Booster phenomenon <!-- PJG 0012 frnewline --> Cluster <!-- PJG 0012 frnewline --> Contact investigation <!-- PJG 0012 frnewline --> Conversions <!-- PJG 0012 frnewline --> Dental settings <!-- PJG 0012 frnewline --> Emergency medical services <!-- PJG 0012 frnewline --> Evaluating PPD conversions <!-- PJG 0012 frnewline --> Frequency <!-- PJG 0012 frnewline --> HCWs with positive PPD tests <!-- PJG 0012 frnewline --> Home-health-care settings <!-- PJG 0012 frnewline --> Immunocompromised workers <!-- PJG 0012 frnewline --> Interpretation of results <!-- PJG 0012 frnewline --> Mantoux technique <!-- PJG 0012 frnewline --> Occupational group <!-- PJG 0012 frnewline --> Persons with HIV infection <!-- PJG 0012 frnewline --> Positive-predictive value <!-- PJG 0012 frnewline --> Pregnancy <!-- PJG 0012 frnewline --> Recent PPD converters <!-- PJG 0012 frnewline --> Recording results <!-- PJG 0012 frnewline --> Self-reading results <!-- PJG 0012 frnewline --> Staggered testing <!-- PJG 0012 frnewline --> Two-step testing <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Preventive therapy <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> Drug-susceptibility testing <!-- PJG 0012 frnewline --> For anergic persons <!-- PJG 0012 frnewline --> Monitoring <!-- PJG 0012 frnewline --> Pregnancy <!-- PJG 0012 frnewline --> Regimens <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            